About
MDG

Medgaea Life Sciences is a third party laboratory that is certificated for OECD GLP, TFDA GLP, ISO 17025 and ISO 9001. Maily based on preclinical CRO, we provide total-soltion services to assist biotechnology industries successfully obtain the product certification and exploit internation market.

view more

 

CRO

  • check

    Needs Discuss

  • check

    Quote and Ordar

  • check

    Timetable Schedule

  • check

    Report Launch

  • done

    Case Closed

view more

Services

With devoting to our core value 『Honesty•Accuracy•Professionalism•Responsibility』,

We have successfully assisted our customers to successfully obtain the product certification in FDA, CE, TFDA and NMPA.

Medical Devices

One of the first priority of medical devices R&D is their safety. The Biocompatibility test is mainly followed the ISO 10993 international standard.

Cell therapy and Regenerative medicine

We assist the safety, effectiveness tests during the R&D process of cell therapy product. All the tests are complied with GLP.

Pharmaceutical development

As the agent of SNBL in Taiwan, will help new drugs company to complete non-clinical trials in medium, large animals and primates in the research and development stage.

Agrochemical and Enviromental Agents

The agroculture products need to review their toxicological data in advance, and all the tests must be carried out in complies with GLP.

Chemical Substances

Providing the toxicological test information!
EPA acquired the test information as the core basis to evaluate the substance announcement.

Health Food/ Ingredients

Provide safety, efficacy and stability tests for food ingredients and health foods.

Registration

Provide registration services.

Pharmaceuticals

Provide batch examine for medicine release, including pyrogen, acute systemic toxicity and other tests.

Laboratory animals and Equipment

An agent and supplier based on research and development of animal experiments, providing import services for various disease model animals in research institutions.

 

台北訊 – 隨著全球健康意識的提升,如何透過天然食材維持健康成為當今熱門議題。為推動最新機能性食品的發展,メドガイア日本(Medgaea Japan) 與 インタートレードヘルスケア(Intertrade Healthcare) 攜手合作,將於 2025 年 3 月 28 日 在台灣保健食品學會年會舉辦午餐研討會,正式介紹來自日本的機能性菇蕈——花瓣茸(Sparassis crispa),探討其在體重管理與更年期保健領域的應用。

 

花瓣茸——日本科研支持的「夢幻菇蕈」

花瓣茸,學名: Sparassis crispa,因其獨特的花狀外觀被譽為「夢幻菇蕈」。近年來的研究發現,花瓣茸含有豐富的β-葡聚醣、多酚與其他具生理活性的成分,對於體脂控制、內臟脂肪調節及更年期症狀緩解 具有顯著功效。本次研討會將邀請日本橫濱藥科大學 總合健康醫療中心的渡邊泰雄教授(Professor Yasuo Watanabe)分享最新科研成果,解析花瓣茸如何透過科學驗證的機制,幫助女性維持健康體態與身心平衡。

 

功能性食品市場趨勢:女性健康需求高漲

台灣市場對於機能性食品的需求日益增加,特別是針對 更年期健康管理、體重控制與內臟脂肪調節 的產品,更是受到消費者的高度關注。根據市場研究數據顯示,全球女性健康市場規模預計將持續擴大,對於天然、科學驗證且無副作用 的機能性食品需求持續攀升。本次研討會將為台灣業界人士提供最新的市場洞察,並探討花瓣茸在亞洲市場的潛在商機。

 

午餐研討會活動資訊

📅 日期: 2025 年 3 月 28 日(星期五)
📍 地點: 台北市福華國際文教會館(Taipei Howard Civil Service International House)
🎤 主講人: 橫濱藥科大學 總合健康醫療中心 渡邊泰雄教授(Professor Yasuo Watanabe)
📝 主題: 「花瓣茸——女性機能性食品新星:抑制過重、內臟脂肪肥胖及更年期不適症狀」
👥 主辦單位: 台灣保健食品學會

【114/03/01 已截止報名】

 

本次研討會將提供最新科學研究數據與市場趨勢分析,適合關注機能性食品、保健市場趨勢及女性健康議題的業界人士參加。期待透過本次國際研討會,共同探索花瓣茸在全球市場的發展潛力,並促進日台企業間的合作與交流。

 

 

1718768977460